Robyna Irshad Khan
Datos Biográficos
| ID | 6764029 |
|---|---|
| NOMBRE | Robyna Irshad Khan |
| NOMBRES | Robyna Irshad |
| APELLIDO | Khan |
| FIRMA | KHAN R I |
| AFILIACIONES | Aga Khan University |
| VERIFICADO | No |
| TOTAL DE OBRAS | 3 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 3 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2023 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2025 |
| ÍNDICE H | 0 |
Enhancing Research Ethics Capacity in Asia
Several Asian countries, including India, Malaysia, Myanmar, and Pakistan, face challenges aligning rapid healthcare and biomedical research growth with necessary ethics oversight. To help address this, the Fogarty International Center of the United States National Institutes of Health funded initiatives to enhance research ethics capacities in these countries. In India, the Yenepoya University's Master's in Research Ethics program was establishe…
Doctors taking bribes from pharmaceutical companies is common and not substantially reduced by an educational intervention
INTRODUCTION: Incentive-linked prescribing, which is when healthcare providers accept incentives from pharmaceutical companies for prescribing promoted medicines, is a form of bribery that harms patients and health systems globally. We developed a novel method using data collectors posing as pharmaceutical company sales representatives to evaluate private doctors' engagement in incentive-linked prescribing and the impact of a multifaceted educati…
Incentivisation practices and their influence on physicians’ prescriptions
Focus on profit-generating enterprise in healthcare can create conflicts of interest that adversely impact prescribing and pricing of medicines. Although a global challenge, addressing the impacts on quality of care is particularly difficult in countries where the pharmaceutical industry and physician lobby is strong relative to regulatory institutions. Our study characterises the range of incentives exchanged between the pharmaceutical industry …
Sin obras prominentes en esta página.
Incentivisation practices and their influence on physicians’ prescriptions
Focus on profit-generating enterprise in healthcare can create conflicts of interest that adversely impact prescribing and pricing of medicines. Although a global challenge, addressing the impacts on quality of care is particularly difficult in countries where the pharmaceutical industry and physician lobby is strong relative to regulatory institutions. Our study characterises the range of incentives exchanged between the pharmaceutical industry …
Doctors taking bribes from pharmaceutical companies is common and not substantially reduced by an educational intervention
INTRODUCTION: Incentive-linked prescribing, which is when healthcare providers accept incentives from pharmaceutical companies for prescribing promoted medicines, is a form of bribery that harms patients and health systems globally. We developed a novel method using data collectors posing as pharmaceutical company sales representatives to evaluate private doctors' engagement in incentive-linked prescribing and the impact of a multifaceted educati…
Enhancing Research Ethics Capacity in Asia
Several Asian countries, including India, Malaysia, Myanmar, and Pakistan, face challenges aligning rapid healthcare and biomedical research growth with necessary ethics oversight. To help address this, the Fogarty International Center of the United States National Institutes of Health funded initiatives to enhance research ethics capacities in these countries. In India, the Yenepoya University's Master's in Research Ethics program was establishe…
Economic growth (2 obras) · Health care (2 obras) · Medicine (2 obras) · Nursing (2 obras) · Pharmaceutical Economics and Policy (2 obras) · Pharmaceutical industry and healthcare (2 obras) · Political science (2 obras) · Alternative medicine (1 obras) · Antibiotic Use and Resistance (1 obras) · Bioethics (1 obras)